Ali Rizvi to Glucose
This is a "connection" page, showing publications Ali Rizvi has written about Glucose.
Connection Strength
0.315
-
Incretin-based therapies, glucometabolic health and endovascular inflammation. Curr Pharm Des. 2014; 20(31):4953-60.
Score: 0.098
-
Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. Metab Syndr Relat Disord. 2014 Feb; 12(1):1-10.
Score: 0.097
-
Levofloxacin-induced hypoglycemia in a nondiabetic patient. Am J Med Sci. 2006 Jun; 331(6):334-5.
Score: 0.058
-
Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us. Metab Syndr Relat Disord. 2022 04; 20(3):137-140.
Score: 0.043
-
Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors. Expert Opin Investig Drugs. 2009 Oct; 18(10):1495-503.
Score: 0.018